Airsculpt Technologies Amends 8-K to Correct Overstated Non-GAAP Financials

summarizeSummary

Airsculpt Technologies amended its recent 8-K to correct an overstatement of approximately $2.6 million in its non-GAAP Adjusted EBITDA and Adjusted Net (Loss)/Income for fiscal year 2025, though GAAP financials and 2026 guidance are unchanged.

check_boxKey Events

• Non-GAAP Financials Corrected

  The company amended its April 2, 2026 8-K to correct errors in non-GAAP financial measures, specifically Adjusted EBITDA, Adjusted EBITDA Margin, and Adjusted Net (Loss)/Income.

• Adjusted EBITDA Overstated by $2.6M

  Adjusted EBITDA and Adjusted Net (Loss)/Income for the twelve months ended December 31, 2025, were overstated by approximately $2.6 million.

• Adjusted EBITDA Margin Overstated

  Adjusted EBITDA Margin was overstated by approximately 7.8% for the fourth quarter of 2025 and 1.7% for the full fiscal year 2025.

• No Impact on GAAP or 2026 Guidance

  The corrections did not affect the company's GAAP financial data or its previously issued 2026 forward-looking guidance.

auto_awesomeAnalysis

Airsculpt Technologies filed an amendment to its April 2, 2026 8-K to correct errors in its non-GAAP financial measures. The company initially overstated Adjusted EBITDA and Adjusted Net (Loss)/Income by approximately $2.6 million for the twelve months ended December 31, 2025. Additionally, Adjusted EBITDA Margin was overstated by 7.8% for Q4 2025 and 1.7% for FY 2025. While these corrections are significant for non-GAAP metrics, the company confirmed that its GAAP financial data and 2026 forward-looking guidance remain unaffected. This amendment follows the recent 10-K filing on March 31, 2026, which disclosed a material weakness in internal controls, suggesting a potential link between the identified errors and the previously reported control deficiencies.